Conference abstractPublished 3 Jul 2013
Novel mass spectrometry method for the quantification of immuno-suppressant drug in human whole blood
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The emergence of drug resistance variants has been the main stumbling blockade to the favorable clinical outcome of chemotherapy. The resistance to one drug often results in cross-resistance to many, if not all, others in the same class. Failure of the current HAART regimen due to drug resistance can severely limit second-line, third-line, and salvage treatment options. The prime causes of drug resistance primarily include the inadequate exposure of the virus to antiretroviral agents, poor adherence to complicated regimens and variability in drug pharmacokinetics. A number of mutations due to application of almost all therapeutic antiHIV-1 drugs especially with nucleoside reverse transcriptase inhibitors (NRTI), non-nucleoside reverse transcriptase inhibitors (NNRTI), anti-proteases and/or a combination of these regimens such as HAART have been selected into different regions of pol gene of HIV-1 encoding the viral enzymes (HIV-1RT, protease and integrase). These mutations alter the function of the target proteins of HIV-1, thus allowing the virus to replicate efficiently even in the presence of antiretroviral agents. Very recently, it is known that these compounds also induce emergence of a compensatory mutation, which is found to be located far from the active site of the enzyme protein. It repairs the functions of altered protein in a way that helps return them back to near normal. It is presumed that these mutations influence the activity of the enzyme by inducing conformational flexibility; however, the detailed mechanistic aspect of this event is still unclear. The present paper includes molecular mechanisms involved in anti-HIV-1 drugs resistance, the development of new drugs that could be active against antiHIV-1 drugs resistant mutants, new targets for effectively arresting the viral replication in human cells and other strategies to combat the scourge.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Analytical & Bioanalytical Techniques
- SubjectBiochemistry & Biotechnology
- SubjectChemistry
- BylineArticles whose byline prints “Anju Aji”
- BylineArticles whose byline prints “Sarita Karthikeyan”
- BylineArticles whose byline prints “Sarabjit Singh”
- BylineArticles whose byline prints “Shivanand Puthli”